In autoimmune demyelinating diseases, an ICAM-1 isoform lacking D4 in the mouse may drive pathogenesis and may be a novel therapeutic target for the treatment of multiple sclerosis (MS) [65,66]. The gene discussed is ICAM1; the disease is multiple sclerosis.